
Factors related to the escapement of reproductive age women from tetanus toxoid vaccination at the Sub – Divisional Medicalized Health Center Nkwen, Bamenda
Abstract
The purpose of this study was to find out the factors related to the escapement of reproductive age women from tetanus toxoid vaccination at the Sub – Divisional Medicalized Health Center Nkwen Bamenda. A cross – sectional hospital based study was conducted in which 100 reproductive aged women (15 – 40 years) were randomly selected to participate. Demographic and clinical data were collected from participants and health personnel using a well – structured pre – tested questionnaire. From the results obtained, most of the women were within the age range of 26 – 30 years (41.1%) and were graduates (40.0%) that were employed (36.7%). Most of the reproductive age women had not taken any dose of the vaccine (54.5%) reasons being that they did not know the time the vaccine was given (80.0%), they were not aware (71.1%) and that they were scared of the side effects (61.0%). From the point of view of the health professionals, misconception about the vaccine (90.0%), poor socio – economic status (90.0%) and lack of awareness (80.0%) were the major reasons of the low tetanus toxoid vaccination coverage. In conclusion, majority of the reproductive age women are not vaccinated and notably, lack of awareness, fear of side effects and not knowing the time the vaccine is given were the main reasons for their escapement.
Keywords
References
Pillitteri A, Pillitteri: Child health nursing: care of the child and family: Lippincott Williams & Wilkins; 1999.
PMid:11072390
Savage EJ, Nash S, McGuinness A, Crowcroft NS: Audit of tetanus prevention knowledge and practices in accident and emergency departments in England. Emergency Medicine Journal 2007, 24:417-421.
http://dx.doi.org/10.1136/emj.2007.047399
PMid:17513539 PMCid:PMC2658278
Allen C, Lueck C: Neurological disease, Chapter 22. Davidson's Principles and practice of medicines, 19th ed. Philedelphia: Churchill Livingstone 2002:1159-1168.
Vandelaer J, Birmingham M, Gasse F, Kurian M, Shaw C, Garnier S: Tetanus in developing countries: an update on the Maternal and Neonatal Tetanus Elimination Initiative. Vaccine 2003, 21:3442-3445.
http://dx.doi.org/10.1016/S0264-410X(03)00347-5
Elimination of Maternal and Neonatal Tetanus (2010). http://wwww.unicef.org/health/index_43509html/ (accessed 10 September 2010).
Deming MS, Roungou J-B, Kristiansen M, Heron I, Yango A, Guenengafo A, Ndamobissi R: Tetanus toxoid coverage as an indicator of serological protection against neonatal tetanus. Bulletin of the World Health Organization 2002, 80:696-703.
PMid:12378286 PMCid:PMC2567620
Elimination of Maternal and Neonatal tetanus by 2005 (online news). http://www.medicalnewstoday.com/medicalnews.php?Newsid=12383 (accessed 9 March 2007).
Organization WH: Organisation mondiale de la santé. Relevé épidémiologique hebdomadaire. Weekly epidemiological record 2006, 81:273-284.
Blencowe H, Lawn J, Vandelaer J, Roper M, Cousens S: Tetanus toxoid immunization to reduce mortality from neonatal tetanus. International Journal of Epidemiology 2010, 39:i102-i109.
http://dx.doi.org/10.1093/ije/dyq027
PMid:20348112 PMCid:PMC2845866
Antai D: Gender inequities, relationship power, and childhood immunization uptake in Nigeria: a population-based cross-sectional study. International Journal of Infectious Diseases 2012, 16:e136-e145.
http://dx.doi.org/10.1016/j.ijid.2011.11.004
PMid:22197748
Brown V, Oluwatosin O: Socio-demographic factors associated with childhood immunization uptake in Akinyele Local Government Area, Oyo State, Nigeria. African journal of medicine and medical sciences 2012, 41:161-167.
PMid:23185914
Dietz V, Milstien JB, Van Loon F, Cochi S, Bennett J: Performance and potency of tetanus toxoid: implications for eliminating neonatal tetanus. Bulletin of the World Health Organization 1996, 74:619.
PMid:9060223 PMCid:PMC2486793
Nusrat N, Nousheen A, M F: Tetanus toxoid vaccination coverage amongst pregnant women at tertiary care hospital, Sindh Pakistan. . Gynaecology and Obstetrics 2010, 6:272-275.
Mohammad M: Determinants of the Utilization of the Tetanus Toxoid (TT) Vaccination Coverage in Bangladesh: Evidence from a Bangladesh Demographic Health Survey 2004. The Internet Journal of Health 2008, 8.
WHO. Global program for vaccine and immunization EPI, WHO, Geneva1998. Edited by.
WHO. Vaccine – preventable diseases monitoring system 2010 global estimates.2010 Available from TTV publication.doc (cited 10 September 2014).
Kidane T, Yigzaw A, Sahilemariam Y, Bulto T, Mengistu H, Belay T, Bisrat F, Benti D, Mbakuliyemo N, Olusegun B: National EPI coverage survey report in Ethiopia, 2006. Ethiopian Journal of Health Development 2009, 22:148-157.
http://dx.doi.org/10.4314/ejhd.v22i2.10065
Hasnain S, Sheikh N: Causes of low tetanus toxoid vaccination coverage in pregnant women in Lahore district, Pakistan. Eastern Mediterranean Health Journal 2007, 13:1142-1152.
PMid:18290408
Mary M: Utilization of tetanus toxoid 1 and 2 immunization service among child bearing age women. 1989 34 (12).
DOI: http://dx.doi.org/10.14259%2Fcs.v2i1.160
Refbacks
- There are currently no refbacks.